- Home
- MPU vs HSCS Comparison
MPU vs HSCS Comparison
Compare MPU & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MPU | HSCS |
|---|---|---|
| Founded | 1989 | 2007 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6M | 15.8M |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MPU | HSCS |
|---|---|---|
| Price | $3.04 | $3.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 79.1K | ★ 136.1K |
| Earning Date | 10-06-2026 | 09-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,319.00 |
| Revenue This Year | N/A | $295.93 |
| Revenue Next Year | N/A | $18,321.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.17 | $1.63 |
| 52 Week High | $3.88 | $5.25 |
Technical Indicators
Market Signals| Indicator | MPU | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 68.96 | 54.67 |
| Support Level | $0.51 | $1.84 |
| Resistance Level | $3.88 | $4.35 |
| Average True Range (ATR) | 0.23 | 0.46 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 65.50 | 45.00 |
Price Performance
Historical ComparisonAbout MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company that offers investors an opportunity to participate in the growth of stablecoins, one of the fastest-evolving sectors in digital assets. The company generated revenue from the Membership and top-up streaming services revenue, Online advertising services, and Content licensing. Geographically, the company operates in the United States and Canada, Asia Pacific, Europe middle east and Africa, and Latin America.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.